Insider Transactions in Q1 2022 at Voyager Therapeutics, Inc. (VYGR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2022
|
Alfred Sandrock President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Mar 21
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
2,649
-2.4%
|
$21,192
$8.49 P/Share
|
|
Mar 21
2022
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
4,955
-2.02%
|
$39,640
$8.49 P/Share
|
|
Mar 21
2022
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,413
-3.81%
|
$35,304
$8.49 P/Share
|
|
Feb 17
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
789
-1.41%
|
$2,367
$3.55 P/Share
|
|
Feb 17
2022
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
4,100
-3.23%
|
$12,300
$3.55 P/Share
|
|
Feb 11
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
361
-0.64%
|
$1,083
$3.36 P/Share
|
|
Feb 11
2022
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,252
-2.5%
|
$9,756
$3.36 P/Share
|
|
Jan 13
2022
|
Michael J Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,205
+50.0%
|
-
|
|
Jan 13
2022
|
Glenn Pierce Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,300
+50.0%
|
-
|
|
Jan 13
2022
|
Robert W. Hesslein Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+13.33%
|
-
|
|
Jan 13
2022
|
Julie Burek VP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+15.09%
|
-
|
|
Jan 12
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
265
-0.57%
|
$795
$3.06 P/Share
|
|
Jan 03
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
3,063
-6.18%
|
$6,126
$2.83 P/Share
|